Literature DB >> 1922681

Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats.

R Invernizzi1, L Pozzi, R Samanin.   

Abstract

The effects of 1-20 mg/kg diazepam were studied on the extracellular concentrations of dopamine (DA), dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the nucleus accumbens and striatum of conscious rats, using intracerebral microdialysis. Five, but not 1 mg/kg diazepam significantly reduced extracellular DA, DOPAC and HVA in the nucleus accumbens. Twenty mg/kg diazepam significantly reduced extracellular DA, DOPAC and HVA in the striatum. A significant effect on striatal DOPAC, but not on DA and HVA, was seen with 10 mg/kg diazepam, while no changes were found with 5 mg/kg diazepam. The results suggest that diazepam reduces the release and metabolism of DA in the nucleus accumbens more than in the striatum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922681     DOI: 10.1016/0028-3908(91)90075-m

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  11 in total

1.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

2.  Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans.

Authors:  Anna R Reynolds; B Levi Bolin; William W Stoops; Craig R Rush
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

3.  Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens.

Authors:  Elif Engin; Konstantin I Bakhurin; Kiersten S Smith; Rochelle M Hines; Lauren M Reynolds; Wannan Tang; Rolf Sprengel; Stephen J Moss; Uwe Rudolph
Journal:  Neuropsychopharmacology       Date:  2014-02-19       Impact factor: 7.853

4.  Negative allosteric modulation of GABAA receptors inhibits facilitation of brain stimulation reward by drugs of abuse in C57BL6/J mice.

Authors:  Matthew E Tracy; Matthew L Banks; Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

Review 5.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

6.  Diazepam alters cocaine self-administration, but not cocaine-stimulated locomotion or nucleus accumbens dopamine.

Authors:  Esther Y Maier; Ramon T Ledesma; Andrew P Seiwell; Christine L Duvauchelle
Journal:  Pharmacol Biochem Behav       Date:  2008-07-20       Impact factor: 3.533

7.  Effects of acute lorazepam administration on aminergic activity in normal elderly subjects: relationship to performance effects and apolipoprotein genotype.

Authors:  Nunzio Pomara; Lisa M Willoughby; Audrey Hashim; Henry Sershen; John J Sidtis; Keith Wesnes; David J Greenblatt; Abel Lajtha
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

Review 8.  α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.

Authors:  Elif Engin; Jing Liu; Uwe Rudolph
Journal:  Pharmacol Ther       Date:  2012-08-18       Impact factor: 12.310

9.  Genetic markers of a Munc13 protein family member, BAIAP3, are gender specifically associated with anxiety and benzodiazepine abuse in mice and humans.

Authors:  Sonja M Wojcik; Martesa Tantra; Beata Stepniak; Kwun-Nok M Man; Katja Müller-Ribbe; Martin Begemann; Anes Ju; Sergi Papiol; Anja Ronnenberg; Artem Gurvich; Yong Shin; Iris Augustin; Nils Brose; Hannelore Ehrenreich
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

10.  Diazepam Concurrently Increases the Frequency and Decreases the Amplitude of Transient Dopamine Release Events in the Nucleus Accumbens.

Authors:  Scott A Schelp; Zachary D Brodnik; Dylan R Rakowski; Katherine J Pultorak; Asha T Sambells; Rodrigo A España; Erik B Oleson
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.